Fragment screening targeting Ebola virus nucleoprotein C-terminal domain identifies lead candidates
- PMID: 32446802
- PMCID: PMC7894038
- DOI: 10.1016/j.antiviral.2020.104822
Fragment screening targeting Ebola virus nucleoprotein C-terminal domain identifies lead candidates
Abstract
The Ebola Virus is a causative agent of viral hemorrhagic fever outbreaks and a potential global health risk. The outbreak in West Africa (2013-2016) led to 11,000+ deaths and 30,000+ Ebola infected individuals. The current outbreak in the Democratic Republic of Congo (DRC) with 3000+ confirmed cases and 2000+ deaths attributed to Ebola virus infections provides a reminder that innovative countermeasures are still needed. Ebola virus encodes 7 open reading frames (ORFs). Of these, the nucleocapsid protein (eNP) encoded by the first ORF plays many significant roles, including a role in viral RNA synthesis. Here we describe efforts to target the C-terminal domain of eNP (eNP-CTD) that contains highly conserved residues 641-739 as a pan-Ebola antiviral target. Interactions of eNP-CTD with Ebola Viral Protein 30 (eVP30) and Viral Protein 40 (eVP40) have been shown to be crucial for viral RNA synthesis, virion formation, and virion transport. We used nuclear magnetic response (NMR)-based methods to screened the eNP-CTD against a fragment library. Perturbations of 1D 1H NMR spectra identified of 48 of the 439 compounds screened as potential eNP CTD interactors. Subsequent analysis of these compounds to measure chemical shift perturbations in 2D 1H,15N NMR spectra of 15N-labeled protein identified six with low millimolar affinities. All six perturbed an area consisting mainly of residues at or near the extreme C-terminus that we named "Site 1" while three other sites were perturbed by other compounds. Our findings here demonstrate the potential utility of eNP as a target, several fragment hits, and provide an experimental pipeline to validate viral-viral interactions as potential panfiloviral inhibitor targets.
Keywords: Drug development; Ebola virus; Fragment screening; Nucleoprotein C-terminal domain.
Copyright © 2020 The Author(s). Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
Figures





Similar articles
-
Ebola virus VP30 and nucleoprotein interactions modulate viral RNA synthesis.Nat Commun. 2017 Jun 8;8:15576. doi: 10.1038/ncomms15576. Nat Commun. 2017. PMID: 28593988 Free PMC article.
-
Backbone resonance assignments and secondary structure of Ebola nucleoprotein 600-739 construct.Biomol NMR Assign. 2019 Oct;13(2):315-319. doi: 10.1007/s12104-019-09898-7. Epub 2019 May 10. Biomol NMR Assign. 2019. PMID: 31076990 Free PMC article.
-
Ubiquitin Ligase WWP1 Interacts with Ebola Virus VP40 To Regulate Egress.J Virol. 2017 Sep 27;91(20):e00812-17. doi: 10.1128/JVI.00812-17. Print 2017 Oct 15. J Virol. 2017. PMID: 28768865 Free PMC article.
-
Contemporary Anti-Ebola Drug Discovery Approaches and Platforms.ACS Infect Dis. 2019 Jan 11;5(1):35-48. doi: 10.1021/acsinfecdis.8b00285. Epub 2018 Dec 20. ACS Infect Dis. 2019. PMID: 30516045 Review.
-
Ebola virus outbreak, updates on current therapeutic strategies.Rev Med Virol. 2015 Jul;25(4):241-53. doi: 10.1002/rmv.1841. Epub 2015 May 11. Rev Med Virol. 2015. PMID: 25962887 Free PMC article. Review.
References
-
- Adams RW, Holroyd CM, Aguilar JA, Nilsson M, Morris GA, 2013. "Perfecting" WATERGATE: clean proton NMR spectra from aqueous solution. Chem Commun (Camb) 49, 358–360. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical